Colazal
Approval Status: Approved July 2000
Colazal is the first oral new chemical entity approved in ten years and the first new therapy approvedin seven years by the FDA for this indication. Salix intends to establish Colazal as the treatment of choice for ulcerative colitis.
Basic Description of Colazal (balsalazide disodium) Capsules
Absorption of Colazal
Clinical Pharmacology
Trials with Colazal
Misc. Info on Colazal
Back to New Treatments
Back to Your Destiny